Jane Street
VRDN icon

Jane Street’s Viridian Therapeutics VRDN Stock Holding History

Jane Street’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,815
Closed -$980K – 13262
2026
Q1 		$1.19M Sell
60,815
-218,792
-78% -$6.5M ﹤0.01% 6143
2025
Q4 		$8.7M Buy
279,607
+244,193
+690% +$6.7M ﹤0.01% 2494
2025
Q3 		$764K Buy
35,414
+24,677
+230% +$445K ﹤0.01% 6897
2025
Q2 		$150K Sell
10,737
-64,449
-86% -$875K ﹤0.01% 8747
2025
Q1 		$1.01M Buy
75,186
+27,164
+57% +$463K ﹤0.01% 5548
2024
Q4 		$921K Sell
48,022
-303,131
-86% -$6.59M ﹤0.01% 5546
2024
Q3 		$7.99M Buy
351,153
+238,078
+211% +$3.89M ﹤0.01% 2170
2024
Q2 		$1.47M Buy
113,075
+63,393
+128% +$878K ﹤0.01% 5047
2024
Q1 		$870K Sell
49,682
-18,286
-27% -$354K ﹤0.01% 5662
2023
Q4 		$1.48M Buy
67,968
+8,332
+14% +$132K ﹤0.01% 4843
2023
Q3 		$915K Sell
59,636
-140,113
-70% -$2.67M ﹤0.01% 5308
2023
Q2 		$4.75M Buy
199,749
+156,704
+364% +$4.02M ﹤0.01% 2812
2023
Q1 		$1.1M Buy
+43,045
New +$1.38M ﹤0.01% 4827
2022
Q2 		– Sell
-61,518
Closed -$1.14M – 11000
2022
Q1 		$1.14M Buy
+61,518
New +$1.18M ﹤0.01% 5867
2019
Q3 		– Sell
-5,174
Closed -$159K – 5816
2019
Q2 		$159K Buy
+5,174
New +$208K ﹤0.01% 4752
2018
Q2 		– Sell
-672
Closed -$71K – 5676
2018
Q1 		$71K Buy
+672
New +$73K ﹤0.01% 4652

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jane Street's VRDN Position: Q2 2026 in Review

Jane Street sold out of Viridian Therapeutics (VRDN) in Q2 2026, closing a stake of 60,815 shares — an estimated $980K sold.

Jane Street first reported a position in VRDN in Q1 2018 and held it in 16 quarters. The position peaked at $8.7M in Q4 2025. 215 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • Jane Street reported no remaining Viridian Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 60,815 Viridian Therapeutics shares in Q2 2026, an estimated $980K.
  • Jane Street first reported a position in Viridian Therapeutics in Q1 2018 and held it in 16 quarters.
  • Jane Street's Viridian Therapeutics position peaked at $8.7M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.